Clearance Summary
RobPath® Total Hip Application received FDA 510(k) clearance under submission number K220774, sponsored by Hangzhou Lancet Robotics Co., Ltd.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Neurology review panel. The statutory decision date of record is 2022-12-09.
- Submission: K220774
- Applicant / Sponsor: Hangzhou Lancet Robotics Co., Ltd.
- Clearance pathway: Traditional
- Review panel: Neurology
- Device class: Class II
- Regulation citation: 21 CFR 882.4560
- Decision date: 2022-12-09
Classification & Regulation
This clearance is catalogued under FDA product code OLO and 21 CFR 882.4560, within the Neurology review panel as a Class II device.